REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960,590 | -65.1% | 83,748 | -23.1% | 0.16% | -59.2% |
| Q2 2023 | $2,755,247 | -21.2% | 108,860 | +0.2% | 0.38% | -24.2% |
| Q1 2023 | $3,498,425 | +278881.3% | 108,613 | +59.9% | 0.51% | +160.5% |
| Q4 2022 | $1,254 | -99.9% | 67,933 | -1.0% | 0.20% | -34.1% |
| Q3 2022 | $1,853,000 | +110.8% | 68,622 | +7.9% | 0.30% | +108.5% |
| Q2 2022 | $879,000 | -30.1% | 63,588 | -1.4% | 0.14% | -9.6% |
| Q1 2022 | $1,258,000 | -40.4% | 64,509 | -50.1% | 0.16% | -35.1% |
| Q4 2021 | $2,112,000 | -42.3% | 129,384 | -1.5% | 0.24% | -46.1% |
| Q3 2021 | $3,659,000 | -6.0% | 131,325 | 0.0% | 0.45% | -0.9% |
| Q2 2021 | $3,892,000 | +0.2% | 131,325 | -5.5% | 0.45% | -4.4% |
| Q1 2021 | $3,885,000 | +78.8% | 138,989 | +81.3% | 0.47% | +75.6% |
| Q4 2020 | $2,173,000 | -13.6% | 76,671 | -23.3% | 0.27% | -25.0% |
| Q3 2020 | $2,514,000 | +53.4% | 100,000 | +49.0% | 0.36% | +33.8% |
| Q2 2020 | $1,639,000 | +10.7% | 67,102 | -32.9% | 0.27% | -10.3% |
| Q1 2020 | $1,480,000 | -31.8% | 100,000 | +14.5% | 0.30% | +17.6% |
| Q3 2018 | $2,171,000 | -9.5% | 87,355 | 0.0% | 0.26% | -15.0% |
| Q2 2018 | $2,398,000 | -30.1% | 87,355 | -21.6% | 0.30% | -33.5% |
| Q1 2018 | $3,430,000 | -19.4% | 111,360 | -6.4% | 0.45% | -19.6% |
| Q4 2017 | $4,253,000 | +47.1% | 118,952 | +13.4% | 0.56% | +42.7% |
| Q3 2017 | $2,891,000 | -12.3% | 104,928 | -16.0% | 0.39% | -16.7% |
| Q2 2017 | $3,298,000 | +60.6% | 124,932 | +26.6% | 0.47% | +46.6% |
| Q1 2017 | $2,053,000 | +8.7% | 98,684 | +8.2% | 0.32% | +3.5% |
| Q4 2016 | $1,888,000 | +35.4% | 91,228 | +6.1% | 0.31% | +38.2% |
| Q3 2016 | $1,394,000 | +25.5% | 86,000 | +5.3% | 0.22% | +21.6% |
| Q2 2016 | $1,111,000 | -22.1% | 81,701 | 0.0% | 0.18% | -24.2% |
| Q1 2016 | $1,426,000 | -41.8% | 81,701 | +13.9% | 0.24% | -36.3% |
| Q4 2015 | $2,449,000 | +14.8% | 71,701 | 0.0% | 0.38% | +9.4% |
| Q3 2015 | $2,134,000 | -6.9% | 71,701 | 0.0% | 0.35% | +1.2% |
| Q2 2015 | $2,293,000 | – | 71,701 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |